孕妇对预防呼吸道合胞病毒(RSV)感染的选择
该研究在澳大利亚招募34名18岁及以上孕妇,通过在线焦点小组讨论或个体访谈,采用主题分析法探讨其对孕产妇RSV免疫规划的障碍与促进因素,以及选择孕妇接种疫苗还是婴儿注射长效单克隆抗体。结果显示,孕妇普遍欢迎并偏好孕产妇RSV疫苗接种,而非其他策略;偏好包括多语言宣传、提醒推送和医疗保健提供者推荐。
要点
- 孕妇接种RSV疫苗的促进因素包括保护婴儿和预防严重疾病。
- 障碍包括疫苗安全担忧、有效性不确定及新冠疫苗接种经历导致的犹豫。
- 孕妇偏好孕产妇免疫而非婴儿免疫,并希望多语言宣传和提醒。
核心结论
- 在本研究中,孕妇普遍欢迎并偏好孕产妇RSV疫苗接种,而非其他策略。
- RSV项目宣传偏好包括语言多样性、「助推」提醒和医疗保健提供者推荐。
研究设计与样本
- 研究纳入居住澳大利亚、年龄18岁及以上的孕妇,开展焦点小组讨论和个体在线访谈,采用主题分析法分析数据。
- 共34名孕妇参与在线焦点小组讨论或访谈,平均年龄34岁。
主要发现
- 识别主题归为四个领域:接种动机为保护婴儿和预防严重疾病;障碍包括疫苗安全担忧、有效性不确定及新冠疫苗接种经历导致的犹豫;偏好宣传策略包括持续提醒/提示、个性化信息、聚焦严重结局且使用多样/通俗语言的宣传活动、当地产科医生和卫生当局推荐;明确疫苗推荐政策及偏好孕产妇免疫而非婴儿免疫。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants and can lead to severe respiratory distress, especially in very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine for pregnant women and monoclonal antibody for infants. This study aimed to identify and understand barriers and facilitators to the uptake of a new RSV vaccine in pregnant women and determine their underlying choices for a maternal RSV immunisation program. Additionally, the study investigated choice for maternal vaccination or administration of a long-lasting monoclonal antibody to infants. METHODS: Eligible participants were pregnant women residing in Australia and aged 18 years or older. Focus group discussions and individual online interviews were conducted and data were analysed using a thematic analysis approach. RESULTS: A total of 34 pregnant women participated in online focus group discussions or interviews, with an average age of 34 years. The identified themes were categorised into four overarching domains: 1) motivators for vaccinating during pregnancy to safeguard their babies and prevent severe diseases, 2) barriers to vaccination including vaccine safety concerns, uncertainties regarding vaccine effectiveness, and vaccine hesitancy arising from COVID-19 vaccination experiences, 3) preferred vaccination promotion strategies, including constant reminders/prompts, personalised messages, campaign focusing on serious outcomes and using diverse/lay languages, recommendations from local obstetricians and health authorities, 4) clear vaccine recommendation policies and a preference for maternal immunisation over infant immunisation. CONCLUSIONS: The maternal RSV vaccination was generally welcomed and preferred by pregnant women in our study comparing to other strategies. Preferences for RSV program promotion included diversity in languages, "nudge" reminders, and recommendations from healthcare providers.
引用
- Wang B, Lassi Z, Andraweera P, et al. Pregnant women's choices for preventing respiratory syncytial virus (RSV). Vaccine. 2025. PMID: 39884912. doi:10.1016/j.vaccine.2025.126790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。